Finished
Postprandial Glycemic and Physiological Responses to Walking With a Wearable Hip Exoskeleton in Patients With Type 2 Diabetes
NCT07692802 · CHA University · Updated 9 July 2026
- What is being tested
- Bot-Fit Aqua Mode; Bot-Fit Boost Mode; Non-Assisted Walking
- For
- Type 2 Diabetes Mellitus (T2DM)
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 55 years to 75 years. About 14 people. The full rules are on the registry page.
- Where
- South Korea
- When
- Starts or started 2 March 2026, ends 24 May 2026. Registered 9 July 2026.
- Results
- None posted yet.
In the researchers' words
This randomized crossover proof-of-concept study evaluated the effects of walking with a wearable hip exoskeleton on postprandial glycemic and physiological responses in patients with type 2 diabetes. Participants completed four experimental conditions: seated control, walking without the wearable hip exoskeleton, walking with the Bot-Fit device in Aqua mode, and walking with the Bot-Fit device in Boost mode. The primary aim was to determine whether walking with the wearable hip exoskeleton alters postprandial glucose responses compared with seated control and conventional walking conditions in patients with type 2 diabetes.
Sites
- CHA UniversitySeongnam-si, Gyeonggi-do, South Korea